Skip to content

Resolute Onyx™ RONYX45015UXRecalls & reported problems

Medtronic, Inc. · STENT RONYX45015UX RESOLUTE ONYX 4.50X15 · Class 3 · Implant

All models of Resolute Onyx (101)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
1
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169557246), received between Jan 8, 2020 and May 6, 2020 — classified as 1 death, 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Death1
  • Myocardial Infarction1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 6, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DURING INDEX PROCEDURE, A RESOLUTE ONYX DRUG ELUTING STENT WAS IMPLANTED. FOLLOWING DAY, PATIENT SUFFERED ELEVATED CARDIAC ENZYMES. CEC ADJUDICATED EVENT A MYOCARDIAL INFARCTION OF UNKNOWN VESSEL.

    Patient problems: Myocardial Infarction

    MAUDE report 10028167 ↗
  • DeathJan 8, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DURING THE INDEX PROCEDURE, ONE RESOLUTE ONYX DES WAS IMPLANTED IN THE LCMA. APPROXIMATELY 21 MONTHS POST INDEX PROCEDURE, PATIENT WAS HOSPITALIZED POST DIALYSIS AND DIED 2 DAYS LATER.

    Patient problems: Death

    MAUDE report 9564270 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page